Top House Dem Buys Stock in Pharma Companies and Defense Contractors
House Budget Chair John Yarmuth is a frequent stock trader who recently purchased shares in companies that are lobbying against the Democrats' budget plan.
Health
Page 3
More and More Medicare Money is Flowing to Private Equity
Recent academic studies have found that private equity investment is rushing in to for-profit healthcare companies, but patients may not benefit.
News Outlet Founded by Blue Dog Dem Operatives Promotes Big Pharma's Lobbying Aims
Leaders of a centrist advocacy group with funding from the pharmaceutical industry founded outlet The Well News and have editorial input on its promoted posts.
Health Care and Hedge Fund Execs Fundraise for Gottheimer as He Leads Moderate Crusade Against Reconciliation Bill
Rep. Josh Gottheimer (D-N.J.) is the unofficial leader of a bloc of conservative Democrats opposing the up to $3.5 trillion budget reconciliation package.
Corporate-Backed Blue Dogs Threaten Democrats’ Budget Plan
Facing health care and climate crises, a group of six conservative House Democrats are seeking to pump the brakes on the largest federal investments in decades.
U.S. Has Worst Health Care Despite Spending the Most On It
Half of lower-income Americans face cost barriers to getting health care, according to a new report from the Commonwealth Fund.
Pharma Companies Spend Billions More on Stock Buybacks Than Developing Drugs, House Report Finds
The largest drugmakers spent $56 billion more on stock buybacks and dividends than on research and development from 2016 to 2020, according to a new House committee report.
Biden Plans to Enact Trump Rule Allowing Drug Companies to Price Gouge on Life-Saving Treatments
The plan, initiated by the Trump administration in January, would gut a key government power for making sure taxpayer-funded pharmaceuticals are available to the public at reasonable prices.
Biden Going Along With Trump's Gutting of Key Drug Price Controls
A last-minute Trump regulation would eliminate a key government authority that could be used against COVID vaccine price hikes.
Astroturf Campaign Attacks Discount Drug Program for the Poor
An anti-government waste group is helping its Big Pharma funder oppose a discount drug program that doesn’t cost the government a penny.